StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
45
This year
6
Publishing Date
2024 - 03 - 29
1
2024 - 03 - 28
1
2024 - 03 - 09
1
2024 - 01 - 22
1
2024 - 01 - 12
1
2024 - 01 - 04
1
2023 - 12 - 01
1
2023 - 11 - 27
1
2023 - 11 - 10
1
2023 - 11 - 07
1
2023 - 10 - 26
1
2023 - 10 - 16
1
2023 - 09 - 04
1
2023 - 09 - 01
1
2023 - 08 - 25
1
2023 - 07 - 19
1
2023 - 07 - 05
2
2023 - 05 - 30
1
2023 - 05 - 23
1
2023 - 05 - 05
1
2023 - 05 - 03
1
2023 - 03 - 28
1
2023 - 01 - 27
1
2023 - 01 - 18
1
2022 - 11 - 07
1
2022 - 11 - 02
1
2022 - 09 - 13
1
2022 - 08 - 29
1
2022 - 07 - 08
1
2022 - 06 - 17
1
2022 - 06 - 14
1
2022 - 04 - 26
1
2022 - 04 - 20
1
2022 - 02 - 01
1
2022 - 01 - 20
1
2022 - 01 - 13
1
2021 - 09 - 22
1
2021 - 09 - 21
1
2021 - 08 - 13
1
2021 - 08 - 12
1
2021 - 08 - 02
1
2021 - 07 - 16
1
2021 - 07 - 07
1
2021 - 05 - 10
1
Sector
Electronic technology
1
Health technology
45
Information
1
Manufacturing
3
N/a
5
Process industries
1
Producer manufacturing
1
Retail trade
1
Technology services
1
Tags
Acquisition
9
Alliances
7
America
31
Antibody
10
Application
12
Approval
22
Asia
8
Biosimilar
21
Biotech-bay
28
Biotech-beach
13
Cancer
91
Cell
7
Clinical-trials-phase-iii
9
Collaboration
10
Companies
11
Conference
35
Deadline
21
Disease
26
Drug
54
Earnings
9
Eb613
11
Europe
15
Events
15
Expected
10
Fda
23
Financial
25
Financial results
13
Gene therapy
7
Global
83
Growing
15
Growth
102
Health
10
Leukemia
10
Liver
7
Lumakras
15
Lung
7
Lung cancer
16
Market
222
N/a
571
Osteoporosis
11
People
26
Pharma
12
Pharmaceuticals
8
Phase 2
15
Phase 3
7
Positive
14
Potential
9
Psoriasis
12
Reach
8
Report
58
Research
45
Results
53
Risk
9
Set
10
Technology
12
Therapeutics
69
Therapy
42
Treatment
46
Trial
13
Update
8
Entities
3m company
99
Abb ltd
165
Abbott laboratories
195
Abbvie inc.
81
Accenture plc
48
Acm research, inc.
59
Agilent technologies, inc.
79
Alphabet inc.
57
Apple inc.
89
Arrival
54
Astrazeneca plc
73
Baxter international inc.
47
Becton, dickinson and company
101
Bio-rad laboratories, inc.
93
Boston scientific corporation
66
Bristol-myers squibb company
80
Broadcom inc.
50
Celanese corporation
49
Cisco systems, inc.
155
Cummins inc.
48
Danaher corporation
128
Denso corp
55
Eastman chemical company
52
Eli lilly and company
148
Ericsson
118
Exxon mobil corporation
52
General electric company
113
Gilead sciences, inc.
54
Glaxosmithkline plc
88
Honeywell international inc.
214
Icon plc
46
Illumina, inc.
59
Infineon technologies ag
61
Intel corporation
136
International business machines corporation
83
Johnson & johnson
318
Koninklijke philips n.v.
120
Laboratory corporation of america holdings
49
Lam research corporation
56
Linde plc
47
Lockheed martin corporation
78
Medtronic plc
132
Microsoft corporation
225
Nec corp
65
Nokia corporation
46
Northrop grumman corporation
62
Novartis ag
129
Nvidia corporation
56
Oracle corporation
192
Orange
745
Panasonic corp
61
Perkinelmer, inc.
53
Pfizer, inc.
51
Qiagen n.v.
62
Raytheon technologies corporation
53
Sanofi
266
Sap se
181
Stryker corporation
72
Teva pharmaceutical industries ltd
59
Thermo fisher scientific inc
257
Symbols
ABBV
7
ABCM
1
ABCZF
1
ABEO
1
ADAP
1
AGEN
1
AKBA
1
ALPMF
2
ALPMY
2
AMGN
45
AMPH
1
AMRX
1
AZN
11
AZNCF
9
BABA
1
BAX
3
BEIGF
5
BGNE
7
BHC
1
BIIB
5
BMY
7
CADL
1
CCXI
6
CIEN
1
CPIX
1
CRSP
1
DD
1
DELL
1
EMKR
1
ENTX
2
ERAS
1
GBIO
1
GILD
1
GLAXF
8
GMAB
1
GNMSF
1
GSK
9
IART
1
INTC
1
JNJ
6
KIDS
1
KPTI
1
LLY
6
LMT
1
MDT
1
MDXG
1
MMM
1
MREO
1
MSFT
1
NMTR
1
NOK
1
NVS
16
NVSEF
13
PFE
2
SNY
10
SNYNF
10
TAK
2
TEVA
2
TEVJF
3
VTRS
3
Exchanges
Nasdaq
45
Nyse
29
Crawled Date
2024 - 03 - 29
1
2024 - 03 - 28
1
2024 - 03 - 09
1
2024 - 01 - 22
1
2024 - 01 - 12
1
2024 - 01 - 04
1
2023 - 12 - 01
1
2023 - 11 - 27
1
2023 - 11 - 10
1
2023 - 11 - 07
1
2023 - 10 - 26
1
2023 - 10 - 16
1
2023 - 09 - 04
1
2023 - 09 - 01
1
2023 - 08 - 25
1
2023 - 07 - 19
1
2023 - 07 - 06
1
2023 - 07 - 05
1
2023 - 05 - 30
1
2023 - 05 - 23
1
2023 - 05 - 05
1
2023 - 05 - 03
1
2023 - 03 - 28
1
2023 - 01 - 27
1
2023 - 01 - 18
1
2022 - 11 - 07
1
2022 - 11 - 02
1
2022 - 09 - 13
1
2022 - 08 - 29
1
2022 - 07 - 08
1
2022 - 06 - 18
1
2022 - 06 - 14
1
2022 - 04 - 26
1
2022 - 04 - 20
1
2022 - 02 - 01
1
2022 - 01 - 20
1
2022 - 01 - 13
1
2021 - 09 - 23
1
2021 - 09 - 21
1
2021 - 08 - 13
1
2021 - 08 - 12
1
2021 - 08 - 02
1
2021 - 07 - 16
1
2021 - 07 - 07
1
2021 - 05 - 10
1
Crawled Time
00:00
2
04:20
1
05:00
2
08:00
1
09:00
6
11:00
4
13:00
2
13:15
1
13:20
1
14:00
3
14:30
2
15:00
1
15:20
2
15:30
1
16:00
5
18:00
4
19:00
1
20:00
1
20:20
1
21:00
1
22:00
2
23:00
1
Source
www.biospace.com
11
www.prnewswire.com
34
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Research
entities :
Amgen inc.
save search
Global Acute Lymphoblastic Leukemia Therapeutics Market Research 2024-2033: Developments Review, Regulatory Landscape, Competitive Benchmarking, Dynamic Landscape
Published:
2024-03-29
(Crawled : 18:00)
- prnewswire.com
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
Email alert
Add to watchlist
GILD
|
$67.07
0.06%
0.06%
8.3M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
Email alert
Add to watchlist
GMAB
|
News
|
$28.47
-0.32%
-0.32%
460K
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
GNMSF
|
News
|
$290.34
3.83%
340
|
Health Technology
|
Email alert
Add to watchlist
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
Email alert
Add to watchlist
research
global
leukemia
therapeutics
market
Global Antibody Therapeutic Industry Research 2023-2024 & 2033: Exploring the Expanding Role in Managing Cancer, Autoimmune Disorders, and Infectious Diseases
Published:
2024-03-28
(Crawled : 15:30)
- prnewswire.com
GLAXF
|
News
|
$19.54
-14.18%
2.6K
|
Health Technology
|
-6.37%
|
O:
0.99%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
0.33%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
2.58%
|
O:
0.52%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-4.85%
|
O:
1.32%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
-4.95%
|
O:
0.02%
H:
0.51%
C:
-0.3%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
-5.91%
|
O:
0.28%
H:
1.71%
C:
-0.3%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-8.24%
|
O:
0.26%
H:
2.03%
C:
1.57%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
-4.64%
|
O:
0.54%
H:
0.0%
C:
0.0%
antibody
research
global
AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD 2024
Published:
2024-03-09
(Crawled : 20:20)
- prnewswire.com
BEIGF
|
$14.29
-9.87%
2.1K
|
n/a
|
Email alert
Add to watchlist
CCXI
|
News
|
$51.99
-0.04%
|
Health Technology
|
Email alert
Add to watchlist
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
Email alert
Add to watchlist
otezla
research
USD 10.40 billion growth in Vascular Endothelial Market between 2022 and 2027, The strategic alliances and collaborations are notably driving market growth-17,000+ Technavio Research Reports
Published:
2024-01-22
(Crawled : 05:00)
- prnewswire.com
SNYNF
|
News
|
$94.25
-2.18%
480
|
Health Technology
|
-7.4%
|
O:
1.71%
H:
0.0%
C:
-0.15%
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
2.69%
|
O:
2.63%
H:
0.8%
C:
0.75%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
-10.28%
|
O:
1.4%
H:
0.0%
C:
0.0%
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
1.32%
|
O:
-0.18%
H:
2.37%
C:
2.28%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-9.13%
|
O:
0.12%
H:
0.39%
C:
0.1%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
2.81%
|
O:
0.57%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-9.04%
|
O:
-0.21%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
7.0%
|
O:
1.8%
H:
0.14%
C:
-0.89%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
-11.31%
|
O:
0.29%
H:
1.12%
C:
0.47%
research
growth
market
Advancing Melanoma Therapeutics: Global Market Insights and In-depth Analysis by BCC Research
Published:
2024-01-12
(Crawled : 11:00)
- prnewswire.com
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
-1.22%
|
O:
2.07%
H:
0.0%
C:
-0.06%
ERAS
|
$1.88
-2.59%
-2.66%
530K
|
|
-3.59%
|
O:
0.0%
H:
4.62%
C:
-1.03%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-8.6%
|
O:
-0.16%
H:
0.43%
C:
0.02%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
2.92%
|
O:
0.25%
H:
0.36%
C:
0.1%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
-9.93%
|
O:
0.71%
H:
0.56%
C:
0.42%
melanoma
research
global
market
Generate:Biomedicines Fortifies Leadership in Generative AI with Advancing Clinical Pipeline and Expanded Amgen Collaboration, Overviewed at the 42nd Annual J.P. Morgan Healthcare Conference
Published:
2024-01-04
(Crawled : 22:00)
- biospace.com/
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
-9.21%
|
O:
0.27%
H:
1.19%
C:
0.55%
conference
pipeline
Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | Growing research in gene therapy for CVDs and orphan diseases is the major market trend- Technavio
Published:
2023-12-01
(Crawled : 08:00)
- prnewswire.com
ALPMF
|
News
|
$9.5
43.47%
1.2K
|
Health Technology
|
-19.29%
|
O:
3.87%
H:
0.0%
C:
0.0%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
-0.54%
|
O:
1.48%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-22.12%
|
O:
-3.37%
H:
4.51%
C:
4.51%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
0.46%
|
O:
-0.25%
H:
0.68%
C:
0.48%
ORTX
|
$16.7
0.0%
370K
|
Health Technology
|
2.53%
|
O:
-0.09%
H:
0.0%
C:
0.0%
GBIO
|
News
|
$2.995
-8.13%
-8.85%
110K
|
Health Technology
|
164.6%
|
O:
0.0%
H:
38.05%
C:
23.01%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-13.71%
|
O:
-0.06%
H:
0.35%
C:
0.29%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
1.25%
|
O:
0.12%
H:
0.97%
C:
0.92%
ADAP
|
$1.085
-4.83%
-5.07%
780K
|
Health Technology
|
116.0%
|
O:
-5.76%
H:
16.36%
C:
15.07%
ABEO
|
News
|
$3.165
-7.19%
-7.74%
2.2M
|
Health Technology
|
-35.83%
|
O:
-2.43%
H:
0.0%
C:
0.0%
research
growing
therapy
market
Global Glioma Treatment Market Research Report 2023: Breakthrough Oncolytic Virus Therapy Offers New Hope for Glioma Patients - Forecast to 2027 and 2032
Published:
2023-11-27
(Crawled : 23:00)
- prnewswire.com
TMO
|
News
|
$577.39
0.49%
0.0%
2M
|
Health Technology
|
17.8%
|
O:
-0.5%
H:
0.0%
C:
0.0%
KPTI
|
$1.1
0.92%
0.91%
1.2M
|
Health Technology
|
54.06%
|
O:
4.0%
H:
1.93%
C:
-7.72%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
3.31%
|
O:
0.03%
H:
0.85%
C:
0.44%
report
hope
treatment
research
global
virus
therapy
market
AMGEN PRESENTS NEW CARDIOVASCULAR RESEARCH AT AHA 2023
Published:
2023-11-10
(Crawled : 14:00)
- prnewswire.com
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
-23.97%
|
O:
2.63%
H:
2.5%
C:
2.35%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
3.39%
|
O:
0.98%
H:
0.49%
C:
0.25%
research
cardiovascular
AMGEN PRESENTS NEW RESEARCH IN EARLY PSORIATIC ARTHRITIS AT ACR 2023
Published:
2023-11-07
(Crawled : 21:00)
- prnewswire.com
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
-27.1%
|
O:
0.66%
H:
1.5%
C:
0.61%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
0.7%
|
O:
0.48%
H:
0.86%
C:
0.31%
research
A large international study of migraine reveals new biological pathways for treatment
Published:
2023-10-26
(Crawled : 18:00)
- biospace.com/
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
0.31%
|
O:
-0.24%
H:
0.71%
C:
-0.66%
international
treatment
migraine
study
AMGEN TO PRESENT NEW RESEARCH FROM ONCOLOGY PORTFOLIO AND PIPELINE AT ESMO 2023
Published:
2023-10-16
(Crawled : 18:00)
- biospace.com/
XNCR
|
$19.05
3.7%
3.57%
760K
|
Health Technology
|
0.9%
|
O:
0.0%
H:
1.49%
C:
0.53%
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
-19.39%
|
O:
-3.15%
H:
2.37%
C:
0.45%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
-3.9%
|
O:
0.14%
H:
1.16%
C:
0.84%
pipeline
research
Addressing the Fragile: 2023 Global Osteogenesis Imperfecta Treatment Market's Growth Driven by Research and Collaboration
Published:
2023-09-04
(Crawled : 16:00)
- prnewswire.com
MREO
|
$2.785
0.18%
0.18%
570K
|
Health Technology
|
Email alert
Add to watchlist
VTRS
|
News
A
|
$11.55
1.67%
1.65%
7.2M
|
Health Technology
|
Email alert
Add to watchlist
KIDS
|
News
|
$31.2
1.86%
1.83%
83K
|
Health Technology
|
Email alert
Add to watchlist
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
News
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
RARE
F
|
$44.26
-1.88%
-1.92%
670K
|
Health Technology
|
Email alert
Add to watchlist
treatment
research
global
collaboration
growth
Anti-rheumatic Market to Grow Exponentially by 2029- Brandessence Market Research
Published:
2023-09-01
(Crawled : 14:30)
- prnewswire.com
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
0.98%
|
O:
1.46%
H:
0.0%
C:
0.0%
ALPMY
|
News
|
$9.49
-1.11%
480K
|
Manufacturing
|
-37.45%
|
O:
-0.07%
H:
3.3%
C:
0.26%
ABBV
|
News
|
$167.8
-1.03%
-0.06%
4.1M
|
Health Technology
|
13.04%
|
O:
-0.35%
H:
0.0%
C:
0.0%
CPIX
|
$1.61
-1.83%
-1.86%
4.5K
|
Health Technology
|
-2.42%
|
O:
0.61%
H:
0.0%
C:
0.0%
BIIB
|
$201.91
4.52%
4.32%
3.3M
|
Health Technology
|
-24.45%
|
O:
0.62%
H:
0.26%
C:
-0.68%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
4.98%
|
O:
0.86%
H:
0.16%
C:
-0.38%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
6.5%
|
O:
0.91%
H:
0.14%
C:
-0.76%
research
market
Minimal Residual Disease Testing Global Markets and Technology Research Report 2023-2028: Charting Cancer Treatment Trajectories - The Role of MRD Explored
Published:
2023-08-25
(Crawled : 14:30)
- prnewswire.com
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
-0.48%
|
O:
-3.27%
H:
3.65%
C:
3.36%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
4.88%
|
O:
0.22%
H:
0.6%
C:
0.31%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
6.39%
|
O:
0.19%
H:
0.25%
C:
-0.28%
disease
report
cancer
treatment
research
global
technology
Nanotechnology Drug Delivery Market to Reach $209.5 Billion, Globally, by 2032 at 9.1% CAGR: Allied Market Research
Published:
2023-07-19
(Crawled : 09:00)
- prnewswire.com
AZNCF
|
News
|
$140.3
-4.19%
1.5K
|
Health Technology
|
0.67%
|
O:
0.47%
H:
1.47%
C:
1.47%
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
10.54%
|
O:
-1.97%
H:
0.0%
C:
0.0%
TEVA
|
$13.01
-0.68%
7.5M
|
Health Technology
|
60.02%
|
O:
1.23%
H:
4.13%
C:
4.01%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-4.94%
|
O:
0.61%
H:
0.6%
C:
-0.84%
BMY
|
$48.86
-0.27%
-0.02%
16M
|
Health Technology
|
-21.19%
|
O:
0.19%
H:
1.19%
C:
-0.1%
AZN
|
News
|
$71.175
0.46%
0.46%
6.1M
|
Health Technology
|
6.63%
|
O:
1.5%
H:
0.75%
C:
-0.32%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
17.39%
|
O:
0.18%
H:
0.67%
C:
-0.4%
drug
reach
research
market
Biosimilars Market Research Report 2023 - Global Forecast to 2028 - Patent Expiries of Blockbuster Biologics and Research into New Indications Presents Opportunities
Published:
2023-07-05
(Crawled : 00:00)
- prnewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-0.61%
|
O:
-1.17%
H:
0.63%
C:
0.22%
LLY
|
News
|
$732.2
-1.81%
0.18%
2.1M
|
Health Technology
|
57.23%
|
O:
-0.55%
H:
0.97%
C:
0.02%
AMRX
|
$6.07
12.41%
11.04%
3.1M
|
Health Technology
|
119.2%
|
O:
-2.54%
H:
10.78%
C:
10.04%
AMPH
|
$40.98
0.17%
0.17%
220K
|
Health Technology
|
-28.94%
|
O:
-0.52%
H:
1.38%
C:
-0.38%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
20.87%
|
O:
-0.43%
H:
0.48%
C:
-0.86%
patent
report
research
global
market
Pharmaceutical Drug Delivery Market to Reach $2,307.27 Billion, Globally, by 2032 at 4.4% CAGR: Allied Market Research
Published:
2023-07-05
(Crawled : 14:00)
- prnewswire.com
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-0.43%
|
O:
0.18%
H:
0.21%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
-0.15%
1.7M
|
Health Technology
|
15.78%
|
O:
-0.74%
H:
0.1%
C:
-0.86%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-13.89%
|
O:
-1.61%
H:
0.06%
C:
-0.51%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
21.33%
|
O:
-0.16%
H:
1.18%
C:
0.54%
drug
reach
research
market
AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) IN PSORIATIC ARTHRITIS AT EULAR 2023
Published:
2023-05-30
(Crawled : 22:00)
- prnewswire.com
BGNE
|
$144.0
3.61%
3.48%
220K
|
Health Technology
|
-36.86%
|
O:
-1.13%
H:
0.19%
C:
-2.1%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
24.93%
|
O:
0.48%
H:
1.03%
C:
0.49%
otezla
research
Atherosclerosis Drugs Market to Reach $27.7 Billion, Globally, by 2032 at 3.0% CAGR: Allied Market Research
Published:
2023-05-23
(Crawled : 09:00)
- prnewswire.com
NVSEF
|
News
|
$96.0
6.88%
52K
|
Health Technology
|
13.64%
|
O:
-1.22%
H:
0.0%
C:
-0.62%
NVS
|
News
|
$98.35
1.1%
0.0%
2.2M
|
Health Technology
|
-2.37%
|
O:
0.74%
H:
0.0%
C:
-1.22%
JNJ
|
News
|
$148.53
-0.69%
-0.14%
9.6M
|
Health Technology
|
-5.32%
|
O:
0.15%
H:
0.74%
C:
-0.18%
BHC
|
$8.56
0.35%
0.0%
2M
|
Health Technology
|
-2.73%
|
O:
-2.27%
H:
4.24%
C:
-2.21%
SNY
|
News
|
$46.66
-2.16%
-2.21%
1.7M
|
Health Technology
|
-14.24%
|
O:
-0.01%
H:
0.0%
C:
0.0%
AMGN
|
News
|
$273.085
-0.17%
-0.17%
2.5M
|
Health Technology
|
21.88%
|
O:
0.1%
H:
1.16%
C:
0.1%
reach
research
market
← Previous
1
2
3
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4323
183.85%
64.77%
220M
|
Consumer Services
BOF
|
$1.99
70.09%
41.21%
110M
|
ILAG
|
$0.51
6.03%
40.62%
1.7M
|
LICN
|
$0.941
68.04%
40.49%
15M
|
AMST
|
$3.31
65.5%
39.58%
70M
|
Technology Services
MTC
|
$3.615
61.38%
38.04%
9.3M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.45
12.5%
30.92%
320K
|
Health Services
MULN
|
News
|
$3.78
38.46%
27.78%
13M
|
Information
RILY
|
$29.86
37.48%
27.26%
12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.